LINCOLN PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16 May 2024
We wish to inform you that the Company participated in investor conference- Call Conference on May 16, 2024. No Unpublished Price Sensitive Information (UPSI) was shared / discussed in the meeting with investors.
Source:
BSE India